Rani Therapeutics Holdings, Inc. (RANI) Stock Forecast
Data as of May 2, 2026Healthcare · Current price $0.94 (+5.85%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Jun 24, 2024 | Annabel Samimy | Stifel Nicolaus | $10.00 | +964.1% |
| Mar 27, 2024 | Edward Nash | Canaccord Genuity | $9.00 | +857.7% |
| Jun 13, 2022 | Andreas Argyrides | Wedbush | $28.00 | +2879.4% |
Top Analysts Covering RANI
RANI vs Sector & Market
| Metric | RANI | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.00 | 2.24 | 2.41 |
| Analyst Count | 3 | 8 | 18 |
| Target Upside | +1567.4% | +1148.3% | +14.9% |
| P/E Ratio | -4.30 | 6.87 | 31.19 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $4M | $5M | $5M | 3 |
| 2027-12-31 | $8M | $9M | $9M | 4 |
| 2028-12-31 | $16M | $16M | $17M | 4 |
| 2029-12-31 | $21M | $22M | $23M | 3 |
| 2030-12-31 | $89M | $93M | $96M | 3 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $-0.25 | $-0.20 | $-0.15 | 3 |
| 2027-12-31 | $-0.28 | $-0.24 | $-0.20 | 3 |
| 2028-12-31 | $-0.33 | $-0.26 | $-0.22 | 3 |
| 2029-12-31 | $-0.30 | $-0.29 | $-0.28 | 1 |
| 2030-12-31 | $-0.12 | $-0.12 | $-0.11 | 1 |
Frequently Asked Questions
What is the analyst consensus for RANI?
The consensus among 3 analysts covering Rani Therapeutics Holdings, Inc. (RANI) is Buy with an average price target of $15.67.
What is the highest price target for RANI?
The highest price target for RANI is $28.00, set by Andreas Argyrides at Wedbush on 2022-06-13.
What is the lowest price target for RANI?
The lowest price target for RANI is $9.00, set by Edward Nash at Canaccord Genuity on 2024-03-27.
How many analysts cover RANI?
3 analysts have issued ratings for Rani Therapeutics Holdings, Inc. in the past 12 months.
Is RANI a buy or sell right now?
Based on 3 analyst ratings, RANI has a consensus rating of Buy (2.00/5) with a +1567.4% upside to the consensus target of $15.67.
What are the earnings estimates for RANI?
Analysts estimate RANI will report EPS of $-0.20 for the period ending 2026-12-31, with revenue estimated at $5M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.